A calm, well reasoned , summary18 May 2026 23:13
After Monday’s strong performance and high volume, I went on to ChatGPT for a summary of the pros & cons as to how attractive SCLP would be to any of the majors in terms of enhancing their drug profile and solving the emerging patent cliff. A very calm , reasoned , summary which I thought was very encouraging - with the caveat, though, that SCLP developments continued to hit target ( which the Board seems to be pretty sure of). I will be tempted to sell a few in the 40p-60p range , leaving me with a large holding in for free with a chance of seeing the ultimate exit price in £ rather than pence. Or am I being delusional?